Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy

Hsueh Liang Chu, Hung Wei Chen, Shin Hua Tseng, Ming Hua Hsu, Li Ping Ho, Fu Hsuan Chou, Md Phd Hsing Yuan Li, Yu Chuan Chang, Pei Hsin Chen, Li Yun Tsai, Ching Chung Chou, Jyh Shin Chen, Tsai Mu Cheng, Chia Ching Chang

研究成果: 雜誌貢獻文章

9 引文 (Scopus)

摘要

It is highly desirable to develop a therapeutic, observable nanoparticle complex for specific targeting in cancer therapy. Growth hormone (GH) and its antagonists have been explored as cancer cell-targeting molecules for both imaging and therapeutic applications. In this study, a low toxicity, biocompatible, therapeutic, and observable GH-nanoparticle complex for specifically targeting growth hormone receptor (GHR) in cancer cells was synthesized by conjugating GH with green fluorescence protein and carboxylated nanodiamond. Moreover, we have shown that this complex can be triggered by laser irradiation to create a "nanoblast" and induce cell death in the A549 non-small-cell lung cancer cell line via the apoptotic pathway. This laser-mediated, cancer-targeting platform can be widely used in cancer therapy. Small but significant: A new nanosurgery platform was formed using a laser-mediated, cancer-targeting nanodiamond (ND) complex. Laser irradiation at 532 nm created a nanoblast of the ND complex and induced cell death within a growth-hormone-receptor-containing lung cancer cell line.
原文英語
頁(從 - 到)1023-1029
頁數7
期刊ChemMedChem
9
發行號5
DOIs
出版狀態已發佈 - 2014

指紋

Nanodiamonds
Growth Hormone
Cells
Lasers
Somatotropin Receptors
Cell death
Laser beam effects
Neoplasms
Nanoparticles
Cell Death
Hormone Antagonists
Therapeutics
Cell Line
Toxicity
Non-Small Cell Lung Carcinoma
Fluorescence
Lung Neoplasms
Imaging techniques
Molecules

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry
  • Molecular Medicine
  • Medicine(all)

引用此文

Chu, H. L., Chen, H. W., Tseng, S. H., Hsu, M. H., Ho, L. P., Chou, F. H., ... Chang, C. C. (2014). Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy. ChemMedChem, 9(5), 1023-1029. https://doi.org/10.1002/cmdc.201300541

Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy. / Chu, Hsueh Liang; Chen, Hung Wei; Tseng, Shin Hua; Hsu, Ming Hua; Ho, Li Ping; Chou, Fu Hsuan; Li, Md Phd Hsing Yuan; Chang, Yu Chuan; Chen, Pei Hsin; Tsai, Li Yun; Chou, Ching Chung; Chen, Jyh Shin; Cheng, Tsai Mu; Chang, Chia Ching.

於: ChemMedChem, 卷 9, 編號 5, 2014, p. 1023-1029.

研究成果: 雜誌貢獻文章

Chu, HL, Chen, HW, Tseng, SH, Hsu, MH, Ho, LP, Chou, FH, Li, MPHY, Chang, YC, Chen, PH, Tsai, LY, Chou, CC, Chen, JS, Cheng, TM & Chang, CC 2014, 'Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy', ChemMedChem, 卷 9, 編號 5, 頁 1023-1029. https://doi.org/10.1002/cmdc.201300541
Chu, Hsueh Liang ; Chen, Hung Wei ; Tseng, Shin Hua ; Hsu, Ming Hua ; Ho, Li Ping ; Chou, Fu Hsuan ; Li, Md Phd Hsing Yuan ; Chang, Yu Chuan ; Chen, Pei Hsin ; Tsai, Li Yun ; Chou, Ching Chung ; Chen, Jyh Shin ; Cheng, Tsai Mu ; Chang, Chia Ching. / Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy. 於: ChemMedChem. 2014 ; 卷 9, 編號 5. 頁 1023-1029.
@article{70d632591c4549d98a89583ee9bfed28,
title = "Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy",
abstract = "It is highly desirable to develop a therapeutic, observable nanoparticle complex for specific targeting in cancer therapy. Growth hormone (GH) and its antagonists have been explored as cancer cell-targeting molecules for both imaging and therapeutic applications. In this study, a low toxicity, biocompatible, therapeutic, and observable GH-nanoparticle complex for specifically targeting growth hormone receptor (GHR) in cancer cells was synthesized by conjugating GH with green fluorescence protein and carboxylated nanodiamond. Moreover, we have shown that this complex can be triggered by laser irradiation to create a {"}nanoblast{"} and induce cell death in the A549 non-small-cell lung cancer cell line via the apoptotic pathway. This laser-mediated, cancer-targeting platform can be widely used in cancer therapy. Small but significant: A new nanosurgery platform was formed using a laser-mediated, cancer-targeting nanodiamond (ND) complex. Laser irradiation at 532 nm created a nanoblast of the ND complex and induced cell death within a growth-hormone-receptor-containing lung cancer cell line.",
keywords = "A549 lung cancer cells, apoptosis, lasers, nanodiamond complexes, recombinant growth hormones",
author = "Chu, {Hsueh Liang} and Chen, {Hung Wei} and Tseng, {Shin Hua} and Hsu, {Ming Hua} and Ho, {Li Ping} and Chou, {Fu Hsuan} and Li, {Md Phd Hsing Yuan} and Chang, {Yu Chuan} and Chen, {Pei Hsin} and Tsai, {Li Yun} and Chou, {Ching Chung} and Chen, {Jyh Shin} and Cheng, {Tsai Mu} and Chang, {Chia Ching}",
year = "2014",
doi = "10.1002/cmdc.201300541",
language = "English",
volume = "9",
pages = "1023--1029",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy

AU - Chu, Hsueh Liang

AU - Chen, Hung Wei

AU - Tseng, Shin Hua

AU - Hsu, Ming Hua

AU - Ho, Li Ping

AU - Chou, Fu Hsuan

AU - Li, Md Phd Hsing Yuan

AU - Chang, Yu Chuan

AU - Chen, Pei Hsin

AU - Tsai, Li Yun

AU - Chou, Ching Chung

AU - Chen, Jyh Shin

AU - Cheng, Tsai Mu

AU - Chang, Chia Ching

PY - 2014

Y1 - 2014

N2 - It is highly desirable to develop a therapeutic, observable nanoparticle complex for specific targeting in cancer therapy. Growth hormone (GH) and its antagonists have been explored as cancer cell-targeting molecules for both imaging and therapeutic applications. In this study, a low toxicity, biocompatible, therapeutic, and observable GH-nanoparticle complex for specifically targeting growth hormone receptor (GHR) in cancer cells was synthesized by conjugating GH with green fluorescence protein and carboxylated nanodiamond. Moreover, we have shown that this complex can be triggered by laser irradiation to create a "nanoblast" and induce cell death in the A549 non-small-cell lung cancer cell line via the apoptotic pathway. This laser-mediated, cancer-targeting platform can be widely used in cancer therapy. Small but significant: A new nanosurgery platform was formed using a laser-mediated, cancer-targeting nanodiamond (ND) complex. Laser irradiation at 532 nm created a nanoblast of the ND complex and induced cell death within a growth-hormone-receptor-containing lung cancer cell line.

AB - It is highly desirable to develop a therapeutic, observable nanoparticle complex for specific targeting in cancer therapy. Growth hormone (GH) and its antagonists have been explored as cancer cell-targeting molecules for both imaging and therapeutic applications. In this study, a low toxicity, biocompatible, therapeutic, and observable GH-nanoparticle complex for specifically targeting growth hormone receptor (GHR) in cancer cells was synthesized by conjugating GH with green fluorescence protein and carboxylated nanodiamond. Moreover, we have shown that this complex can be triggered by laser irradiation to create a "nanoblast" and induce cell death in the A549 non-small-cell lung cancer cell line via the apoptotic pathway. This laser-mediated, cancer-targeting platform can be widely used in cancer therapy. Small but significant: A new nanosurgery platform was formed using a laser-mediated, cancer-targeting nanodiamond (ND) complex. Laser irradiation at 532 nm created a nanoblast of the ND complex and induced cell death within a growth-hormone-receptor-containing lung cancer cell line.

KW - A549 lung cancer cells

KW - apoptosis

KW - lasers

KW - nanodiamond complexes

KW - recombinant growth hormones

UR - http://www.scopus.com/inward/record.url?scp=84899966383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899966383&partnerID=8YFLogxK

U2 - 10.1002/cmdc.201300541

DO - 10.1002/cmdc.201300541

M3 - Article

C2 - 24677633

AN - SCOPUS:84899966383

VL - 9

SP - 1023

EP - 1029

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 5

ER -